Medicamen Organics Limited

About the company

## **About Medicamen Organics Limited** Medicamen Organics Limited are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer / third party manufacturer.  They distribute their products to private pharmaceutical companies both domestically and internationally via third-party distributors or on a loan license basis. Their products are available across India and in numerous African, CIS, and Southeast Asian countries, including Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, the Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya, thanks to their third-party distribution network. They have 2 WHO GMP approved manufacturing facilities located at Uttarakhand. Their  manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. Also they have in-house testing laboratory and necessary infrastructure to test raw materials and finished products to match the quality standards. They are regularly engaged in research and development and launching new products. This gives us an exhaustive product list as well as fair pricing in the market. Their product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS). **Business Model:** **Contract Manufacturing** : Their primary business model is B2B contract manufacturing models where they partner with pharmaceutical companies who are third-party providers who market and sell the products to various companies engaged in ethical marketing as well as generics in International Market and Domestic Markets and has strong and independent sales and distribution networks for the marketing of our products. They have entered into contract manufacturing with 44 domestic partners and 12 merchant exporters. **Government Contract:**   They participate in government tenders for supply of the product as per their requirement to government hospitals, government departments, Government PSU, Government armed forces etc. (“Government Contracts”). The advantages of government business include bulk quantity, committed volume, and advantages in purchase price due to high volume. They have served 11 government institution as of March, 2024. The company is consistent in supplying quality products round the year &  products comply with requisite safety standards. They prioritise the implementation of total quality management techniques. They are a quality conscious company & constantly striving to expand their line of products and are always looking for complementary products that will add to their range of products. Medicamen Organics Limited Prepares for its Initial Public Offering (IPO), the proceeds generated from the Fresh Issue will be allocated towards crucial objectives: 1. Funding of expenses proposed to be incurred towards Product registration in the international markets 1. Plant updation and increase in production capacity 1. Funding working capital requirements of our Company 1. General Corporate Purposes.

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   21 Jun 2024

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   25 Jun 2024

   Last day to place your bid

3. Basis of Allotment

   Completed
   23 Jun 2024

   Share allotment finalised

4. Refund Initiation

   Completed
   27 Jun 2024

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   26 Jun 2024

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   28 Jun 2024

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.